TherapeuticsMD Inc (TXMD)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

TherapeuticsMD Announces First Quarter 2026 Financial Results

TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 8-K - Current report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

TherapeuticsMD Announces Full Year 2025 Financial Results

TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported...

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

TherapeuticsMD Announces Third Quarter 2025 Financial Results

TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities